Download PDF
1 / Pages

Other users also viewed these articles

Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis Luis Vega; Daniela Simian; Abraham I. Gajardo; Marcelo Salinas; Andrea Urra; Máximo Cattaneo; Rosario Pino; Juan P. Roblero; Álvaro Urzúa; Katherine Rojas; Jaime Poniachik;
10.1016/j.aohep.2024.101511
O-16 DIFFERENCES IN HEPATOCARCINOMA IN PATIENTS WITH CIRRHOSIS DUE TO NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) VS. OTHER ETIOLOGIES Jimmy Sanga; Daniela Simian; Federico Aronsohn; Jaime Poniachik;
Ann Hepatol. 2024;29 Supl 1:
P- 35 COMPLICATIONS ASSOCIATED TO THE LIVER TRANSPLANTATION IN PATIENTS WITH CIRRHOTIC CARDIOMYOPATHY José Ignacio Ruiz; Verónica Marín; Daniela Simian; Pamela Smith; Juan Pablo Roblero; Álvaro Urzúa; Máximo Cattaneo; Marcelo Llancaqueo; Andrés Palma; Jaime Poniachik;
Ann Hepatol. 2024;29 Supl 1: